Therapeutic vaccines may fill GSK pipeline, CEO says

07/31/2008 | Yahoo!

Therapeutic vaccines designed to treat cancer and other disorders by triggering the immune system to attack certain proteins may become one of GlaxoSmithKline's important product lines, CEO Andrew Witty said. The drugmaker is conducting late-stage studies of MAGE-A3, a vaccine against lung cancer and melanoma that targets MAGE-3 -- a protein common in some cancers but not in healthy cells.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR